Related Experiment Video

Updated: Aug 12, 2026

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
15:57

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on: July 11, 2015

Interferon gamma levels in pleural fluid for the diagnosis of tuberculosis

Victoria Villena1, Angel López-Encuentra, Francisco Pozo

  • 1Servicio de Neumologia, Hospital 12 de Octubre, Madrid, Spain. mvg01m@saludia.com

The American Journal of Medicine
|October 14, 2003
PubMed

Insights

Elevated pleural interferon gamma levels are highly valuable for diagnosing tuberculosis (TB). A cutoff of 3.7 IU/mL offers excellent sensitivity and specificity for TB diagnosis in pleural effusions.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Diagnostic Immunology

Background:

  • Pleural effusions are common clinical challenges.
  • Accurate diagnosis of tuberculosis (TB) in pleural effusions is crucial.
  • Interferon gamma (IFN-γ) is a cytokine implicated in cell-mediated immunity.

Purpose of the Study:

  • To evaluate the diagnostic utility of pleural fluid interferon gamma levels for tuberculosis.
  • To determine the optimal cutoff value for interferon gamma in diagnosing pleural TB.

Main Methods:

  • Prospective study of patients with pleural effusions at a tertiary care hospital.
  • Interferon gamma levels measured by radioimmunoassay.
  • Tuberculosis diagnosis confirmed by established criteria.

Main Results:

  • Of 595 patients, 82 (14%) had TB.
  • Interferon gamma demonstrated high diagnostic accuracy (AUC 0.99).
  • A cutoff of 3.7 IU/mL achieved 98% sensitivity and 98% specificity for TB.

Conclusions:

  • Elevated pleural interferon gamma levels (>3.7 IU/mL) are highly effective for diagnosing pleural tuberculosis.
  • The test maintains accuracy across different patient demographics and effusions.
  • Slightly elevated levels may occur in hematologic malignancies, but are distinct from TB levels.
Abstract

More Related Videos

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection09:54

Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection

Published on: February 16, 2020

Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection09:11

Imaging of In Situ Interferon Gamma Production in the Mouse Spleen following Listeria monocytogenes Infection

Published on: July 16, 2019

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...